- Home
- AMLX vs CDNL Comparison
AMLX vs CDNL Comparison
Compare AMLX & CDNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | CDNL |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | 1480 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMLX | CDNL |
|---|---|---|
| Price | $18.08 | $74.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $21.56 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 1.8M | 829.3K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $50.30 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $7.48 | $21.98 |
| 52 Week High | $19.15 | $96.40 |
Technical Indicators
Market Signals| Indicator | AMLX | CDNL |
|---|---|---|
| Relative Strength Index (RSI) | 69.75 | 51.04 |
| Support Level | $12.17 | $46.59 |
| Resistance Level | $18.61 | N/A |
| Average True Range (ATR) | 1.04 | 7.93 |
| MACD | 0.33 | 0.00 |
| Stochastic Oscillator | 83.43 | 30.52 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About CDNL Cardinal Infrastructure Group Inc. Class A Common Stock
Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. The company provides wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. It derives all revenue in the United States of America from construction projects based in North Carolina and South Carolina.